Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Emma Rose 2025 Aug 15, 00:00

Fed Rate Cut Uncertainty Looms: Powell Navigates Rising Pressure

Liam James 2025 Aug 15, 00:00

Bitcoin and Ethereum Surge to New Highs Amidst Market Optimism

Sophia Claire 2025 Aug 15, 00:00

US Treasury Secretary Bessent Defends Fed Rate Cut Comments, Citing Model Suggestion

Noah Lee 2025 Aug 15, 00:00

Fundstrat Bullish on Ethereum: Growth Drivers and Price Predictions

Frances Wang 2025 Aug 14, 16:00

Stock market today: FTSE 100, DAX 30, CAC 40, Nikkei 225

Indices
Frances Wang 2025 Aug 14, 16:00

Shiba Inu Coin News: What’s Going on With Shiba Coin?

Cryptocurrencies
Liam James 2025 Aug 14, 00:00

US Interest Rate Cut Debate Heats Up: Will September See Action?

Emma Rose 2025 Aug 14, 00:00

Easing Sanctions on Russia: A Delicate Balance Between Ceasefire and European Interests

Info

Spread

0.07

Spread (%)

0.7338 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1531639552

Shares Outstanding

162422000

Earnings Date (Next)

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

2.22

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot